Literature DB >> 15754422

GM1 stabilizes expression of NMDA receptor subunit 1 in the ischemic hemisphere of MCAo/reperfusion rat.

Jian-ren Liu1, Mei-ping Ding, Er-qing Wei, Jian-hong Luo, Ying Song, Jian-zheng Huang, Qiu-fu Ge, Hua Hu, Li-jun Zhu.   

Abstract

OBJECTIVE: To determine the protective effect of monosialoganglionside (GM1) and evaluate the influence of GM1 on expression of N-methyl-D-aspartate receptor subunit 1 (NMDAR1) in Sprague-Dawley (SD) rats with focal cerebral ischemia-reperfusion (I/R).
METHODS: Left middle cerebral artery (MCA) was occluded by an intraluminal suture for 1 h and the brain was reperfused for 72 h in SD rats when infarct volume was measured, GM1 (10 mg/kg) was given ip (intraperitoneally) at 5 min (group A), 1 h (group B) and 2 h (group C) after MCA occlusion (MCAo). Expression of NMDAR1 was detected by Western blot at various time after reperfusion (4 h, 6 h, 24 h, 48 h and 72 h) in ischemic hemispheres of the rats with or without GM1 administered.
RESULTS: (1) Adjusted relative infarct volumes of groups A and B were significantly smaller than that of group C and the control group (P<0.01 and P<0.05, respectively). (2) Expression level of NMDAR1 was temporally high at 6 h after reperfusion, and dipped below the normal level at 72 h after reperfusion. GM1 at 5 min after MCAo significantly suppressed the expression of NMDAR1 at 6 h after reperfusion (P<0.05 vs the control). At 72 h after reperfusion, the NMDAR1 expression level of rats treated with GM1 administered (at 5 min or 2 h after MCAo) was significantly higher than that of the control (P<0.05).
CONCLUSION: GM1 can time-dependently reduce infarct volume in rats with focal cerebral I/R partly through stabilizing the expression of NMDAR1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754422      PMCID: PMC1389733          DOI: 10.1631/jzus.2005.B0254

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  20 in total

1.  Gangliosides normalize distorted single-cell intracellular free Ca2+ dynamics after toxic doses of glutamate in cerebellar granule cells.

Authors:  G A de Erausquin; H Manev; A Guidotti; E Costa; G Brooker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 2.  The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.

Authors:  D W Choi; S M Rothman
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

Review 3.  Excitatory amino acid receptors and synaptic plasticity.

Authors:  G L Collingridge; W Singer
Journal:  Trends Pharmacol Sci       Date:  1990-07       Impact factor: 14.819

Review 4.  The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system.

Authors:  D T Monaghan; R J Bridges; C W Cotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

5.  Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: protection by synthetic derivatives of endogenous sphingolipids.

Authors:  H Manev; M Favaron; S Vicini; A Guidotti; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

6.  Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

Authors:  C Wahlestedt; E Golanov; S Yamamoto; F Yee; H Ericson; H Yoo; C E Inturrisi; D J Reis
Journal:  Nature       Date:  1993-05-20       Impact factor: 49.962

7.  GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.

Authors:  R P Simon; J Chen; S H Graham
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

8.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

9.  Semisynthetic sphingolipids prevent protein kinase C translocation and neuronal damage in the perifocal area following a photochemically induced thrombotic brain cortical lesion.

Authors:  A Kharlamov; A Guidotti; E Costa; R Hayes; D Armstrong
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

10.  Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations.

Authors:  R L Michaels; S M Rothman
Journal:  J Neurosci       Date:  1990-01       Impact factor: 6.167

View more
  5 in total

1.  Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia.

Authors:  Fernando D Testai; John P Kilkus; Evgeny Berdyshev; Irina Gorshkova; Viswanathan Natarajan; Glyn Dawson
Journal:  J Neurochem       Date:  2014-08-14       Impact factor: 5.372

2.  Changes in the metabolism of sphingolipids after subarachnoid hemorrhage.

Authors:  Fernando D Testai; Hao-Liang Xu; John Kilkus; Vidyani Suryadevara; Irina Gorshkova; Evgeny Berdyshev; Dale A Pelligrino; Glyn Dawson
Journal:  J Neurosci Res       Date:  2015-01-19       Impact factor: 4.164

3.  Systems pharmacology analysis of synergy of TCM: an example using saffron formula.

Authors:  Jianling Liu; Jingjing Liu; Fengxia Shen; Zonghui Qin; Meng Jiang; Jinglin Zhu; Zhenzhong Wang; Jun Zhou; Yingxue Fu; Xuetong Chen; Chao Huang; Wei Xiao; Chunli Zheng; Yonghua Wang
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

Review 4.  GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.

Authors:  Elena Chiricozzi; Giulia Lunghi; Erika Di Biase; Maria Fazzari; Sandro Sonnino; Laura Mauri
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

5.  Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.

Authors:  Wenchao Zhang; Paul R Krafft; Tianlong Wang; John H Zhang; Li Li; Jiping Tang
Journal:  Cell Transplant       Date:  2019-01-22       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.